156 related articles for article (PubMed ID: 7803728)
1. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
Littrup PJ; Goodman AC
In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
[TBL] [Abstract][Full Text] [Related]
2. Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Littrup PJ; Goodman AC; Mettlin CJ; Murphy GP
J Urol; 1994 Nov; 152(5 Pt 2):1873-7. PubMed ID: 7523734
[TBL] [Abstract][Full Text] [Related]
3. The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Littrup PJ; Goodman AC; Mettlin CJ
CA Cancer J Clin; 1993; 43(3):134-49. PubMed ID: 7683964
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
6. [Screening of prostate carcinoma].
Trinkler FB
Ther Umsch; 1995 Jun; 52(6):393-8. PubMed ID: 7541568
[TBL] [Abstract][Full Text] [Related]
7. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
Krahn MD; Coombs A; Levy IG
CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
[TBL] [Abstract][Full Text] [Related]
8. Future benefits and cost-effectiveness of prostate carcinoma screening. American Cancer Society.
Littrup PJ
Cancer; 1997 Nov; 80(9):1864-70. PubMed ID: 9351561
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of prostate cancer screening in Thai elderly.
Tantiwong A; Soontrapa S; Sujijantrarat P; Vanprapar N; Sawangsak L
J Med Assoc Thai; 2002 Apr; 85(4):502-8. PubMed ID: 12118499
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
11. [Screening of cancer of the prostate (IV). Economic approach: the costs of screening tests and treatment. Members of the Sub-Committee of the Prostate of CCAFU].
Haillot O; Villers A; Soulie M; Baron JC
Prog Urol; 1998 Sep; 8(4):517-23. PubMed ID: 9834514
[TBL] [Abstract][Full Text] [Related]
12. A quantitative analysis of the costs and benefits of prostate cancer screening.
Benoit RM; Grönberg H; Naslund MJ
Prostate Cancer Prostatic Dis; 2001; 4(3):138-145. PubMed ID: 12497031
[TBL] [Abstract][Full Text] [Related]
13. Screening and early detection for prostate cancer.
Magoha GA
East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
Lim LS; Sherin K;
Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective.
Kobayashi T; Goto R; Ito K; Mitsumori K
Eur J Surg Oncol; 2007 Aug; 33(6):783-9. PubMed ID: 17408910
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of prostate cancer detected by digital rectal examination only.
Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
[TBL] [Abstract][Full Text] [Related]
18. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
[TBL] [Abstract][Full Text] [Related]
19. [Screening for early detection of prostate cancer (first experience in Israel)].
Neheman A; Shotland Y; Metz Y; Stein A
Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
[TBL] [Abstract][Full Text] [Related]
20. Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.
Shim HB; Lee SE; Park HK; Ku JH
Prostate Cancer Prostatic Dis; 2007; 10(3):250-5. PubMed ID: 17297501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
